TWiV 50: XMRV

Hosts: Vincent Racaniello and Jason Rodriguez

Vincent and Jason review influenza 2009 H1N1 vaccine trials and protection against the virus conferred by the 1976 swine flu vaccine, then move on to a virus called XMRV and its possible role in prostate cancer.

Sponsor: Try GotoMyPC free for 30 days! For this special offer, visit www.gotomypc.com/podcast

Click the arrow above to play, or right-click to download TWiV #50 (54 MB .mp3, 74 minutes)

Subscribe to TWiV in iTunes, by the RSS feed, or by email

Links for this episode:

• One dose of influenza 2009 H1N1 vaccine without adjuvant is enough
• Partially completed study on influenza 2009 H1N1 vaccine with MF59 adjuvant
• 1976 swine flu vaccine induces cross-reactive antibodies against influenza 2009 H1N1 strain
• Explanation of hemagglutination-inhibition and microneutralization assays
• FDA approves influenza 2009 H1N1 vaccine
• XMRV is present in malignant prostatic epithelium and is associated with prostate cancer
• Identification of a novel gammaretrovirus in prostate tumors
• CDC page on Guillain-Barré syndrome

Weekly Science Picks
Jason Glass Microbiology
Vincent FluWeb Influenza Historical Resources Database

Send your virology questions and comments (email or mp3 file) to twiv@twiv.tv or leave voicemail at Skype: twivpodcast. You can also send articles that you would like us to discuss to delicious and tagging them with to:twivpodcast.

• 

Tagged as: adjuvant, guillain-barré, H1N1, influenza, mf59, pandemic, retrovirus, swine flu, vaccine, viral, virology, virus, XMRV